Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis

Author： Lu Chien-Yi   Chang Yi-Chih   Hua Chun-Hung   Chuang Chieh   Huang Su-Hua   Kung Szu-Hao   Hour Mann-Jen   Lin Cheng-Wen  

Publisher： MDPI

E-ISSN： 1422-0067|18|5|954-954

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.18, Iss.5, 2017-05, pp. : 954-954

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiviral Activity of Baicalein and Quercetin against the Japanese Encephalitis Virus

By Johari Jefree   Kianmehr Aynaz   Mustafa Mohd Rais   Abubakar Sazaly   Zandi Keivan  

International Journal of Molecular Sciences, Vol. 13, Iss. 12, 2012-12 ,pp. : 16785-16795

MDPI

Access to resources Recommend Favorite

HDAC6 and Ovarian Cancer

By Haakenson Joshua   Zhang Xiaohong  

International Journal of Molecular Sciences, Vol. 14, Iss. 5, 2013-05 ,pp. : 9514-9535

MDPI

Access to resources Recommend Favorite

Antiviral Activity of a Novel Compound CW-33 against Japanese Encephalitis Virus through Inhibiting Intracellular Calcium Overload

By Huang Su-Hua   Lien Jin-Cherng   Chen Chao-Jung   Liu Yu-Ching   Wang Ching-Ying   Ping Chia-Fong   Lin Yu-Fong   Huang An-Cheng   Lin Cheng-Wen  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-08 ,pp. : 1386-1386

MDPI

Access to resources Recommend Favorite

Identification and Analysis of Differentially-Expressed microRNAs in Japanese Encephalitis Virus-Infected PK-15 Cells with Deep Sequencing

By Cai Yuhan   Zhu Ling   Zhou Yuanchen   Liu Xiao   Liu Xiaowan   Li Xinqiong   Lang Qiaoli   Qiao Xiaogai   Xu Zhiwen  

International Journal of Molecular Sciences, Vol. 16, Iss. 1, 2015-01 ,pp. : 2204-2219

MDPI

Access to resources Recommend Favorite

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors

By Thomas Elizabeth A.  

Pharmaceuticals, Vol. 7, Iss. 6, 2014-05 ,pp. : 634-661

MDPI

Access to resources Recommend Favorite